PANMRA-24-P-0000_005879 AI for Infectious Disease Threats
Closed Special Notice Posted
- Solicitation number
- PANMRA-24-P-0000_005879
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Silver Spring, Maryland 20910, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Special Notice is issued by the Defense Health Agency (DHA) to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract for Artificial Intelligence (AI)/Machine-Learning (ML) in silico screening of candidate drug compounds against known targets of infectious disease threats. This is a sole-source contract opportunity and not a request for competitive proposals.
The purpose of this contract is to screen millions of approved and novel compounds against multiple targets identified by the Government to identify and develop drug-like ligands. The contractor will utilize ML decision tree algorithms to identify potent compounds and evaluate their potential toxicity, off-target effects, and metabolic liabilities. The contract has a posted date of October 3, 2024, and a due date of October 18, 2024. Eligible contractors must have the capability to conduct the required in silico screening at their own facilities. The NAICS code for this opportunity is 541714 - Research and Development in Biotechnology (except Nanobiotechnology), and the PSC code is B529-P - Special Studies/Analysis- Scientific Data.
Notice text
THIS IS A NOITICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPSALS.
The Experimental Therapeutics (ET) Branch would like to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract for Artificial Intelligence (AI)/Machine-Learning (ML) in silico screening of candidate drug compounds against known targets of infectious disease threats of interest. In their own facilities, the contractor will screen multimillions of approved and novel compounds against multiple targets to be identified by the Government to identify and develop drug-like ligands. The contractor will utilize ML decision tree algorithms for potent compound identification followed by evaluation of potential toxicity, off-target effects and potential structure based metabolic liabilities.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Special Notice | |
| PANMRA-24-P-0000_005879 AI for Infectious Disease Threats | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity